Universal Beteiligungs und Servicegesellschaft mbH Reduces Stake in Agilent Technologies, Inc. $A

Universal Beteiligungs und Servicegesellschaft mbH reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 8.6% in the fourth quarter, Holdings Channel reports. The fund owned 577,074 shares of the medical research company’s stock after selling 54,276 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Agilent Technologies were worth $78,665,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of A. Massachusetts Financial Services Co. MA grew its holdings in Agilent Technologies by 13.8% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after purchasing an additional 1,713,216 shares during the period. Wellington Management Group LLP raised its stake in shares of Agilent Technologies by 4.8% in the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after buying an additional 433,342 shares during the period. Generation Investment Management LLP lifted its position in shares of Agilent Technologies by 10.1% during the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after buying an additional 582,093 shares during the last quarter. Ameriprise Financial Inc. grew its stake in shares of Agilent Technologies by 15.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,708,591 shares of the medical research company’s stock worth $347,685,000 after acquiring an additional 354,480 shares during the period. Finally, Troy Asset Management Ltd increased its holdings in Agilent Technologies by 0.3% in the 3rd quarter. Troy Asset Management Ltd now owns 2,404,161 shares of the medical research company’s stock worth $308,574,000 after acquiring an additional 6,341 shares during the last quarter.

Wall Street Analysts Forecast Growth

A has been the topic of a number of research reports. Morgan Stanley lowered their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. HSBC assumed coverage on shares of Agilent Technologies in a research note on Tuesday, January 20th. They issued a “buy” rating and a $180.00 target price for the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. TD Cowen cut their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Finally, Barclays lowered their target price on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies has a consensus rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Stock Down 1.2%

Shares of NYSE:A opened at $120.56 on Thursday. The stock’s 50-day moving average price is $117.67 and its 200-day moving average price is $133.53. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. Agilent Technologies, Inc. has a 12-month low of $103.16 and a 12-month high of $160.27. The stock has a market capitalization of $34.07 billion, a P/E ratio of 26.61, a price-to-earnings-growth ratio of 2.57 and a beta of 1.30.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period last year, the company posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st were paid a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s payout ratio is presently 22.52%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.